NMTR - HVBT PSTI and DPW among pre market gainers

August, 16 2021 08:42 AM 9 Meters Biopharma Inc.

Enlivex Therapeutics ENLV +22% to launch Phase IIb Allocetra trial for COVID-19 patients in Israel ADMA Biologics ADMA +17% on FDA approval for plasma collection facility in Maryville, TN Travere Therapeutics TVTX +17% meets primary efficacy endpoint in late-stage trial for IgA nephropathy NanoVibronix (NASDAQ:NAOV) +17%. Immersion Corporation (NASDAQ:IMMR) +8%. Sonos SONO +10% after Morgan Stanley says bull case is activated Ault Global Holdings DPW +9% on Q2 earnings. Qumu Corporation (NASDAQ:QUMU) +9%. CureVac N.V. CVAC +9% after second-generation COVID-19 vaccine shows improved immune response Evoke Pharma (NASDAQ:EVOK) +8%. CVD Equipment (NASDAQ:CVV) +7%. Pluristem Therapeutics (NASDAQ:PSTI) +7%. Future FinTech (NASDAQ:FTFT) +7%. 9 Meters Biopharma (NASDAQ:NMTR) +5% announces collaboration with EBRIS foundation for planned Phase 2 study of Larazotide for the treatment of Multisystem Inflammatory Syndrome in Children (MIS-C) resulting from COVID-19 Minim, Inc. Common Stock (NASDAQ:MINM) +6%. Data Storage (NASDAQ:DTST) +6% on Q2 earnings. Blade Air Mobility BLDE +6% on Q3 earnings. Can-Fite BioPharma (NYSE:CANF) +6%. OpGen (NASDAQ:OPGN) +5%. Hive Blockchain Technologies (NASDAQ:HVBT) +5%.

For further details see:

HVBT, PSTI and DPW among pre market gainers

Company Name:	9 Meters Biopharma Inc.
Stock Symbol:	NMTR
Market:	NASDAQ

Twitter